Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Navigating the Shoals of Cutaneous T-cell Lymphoma: Challenges and Controversies in Management of Special Populations
Description
Dr. Jennifer Villasenor Park discussed challenges in managing pediatric cutaneous T-cell lymphoma (CTCL) during a presentation. Pediatric CTCL is rare, with an incidence of 0.1 to 0.3 per million among children aged 0-19, typically diagnosed between ages 9-11, and exhibits a male predominance. Diagnosis is often delayed, ranging from one to twenty-four years, due to its mimicry of benign skin conditions. The most common type in children is mycosis fungoides, particularly the hypopigmented variant, which presents distinctively different in children compared to adults. Treatment generally involves skin-directed therapies, such as phototherapy and topical steroids, which have been effective and safe in early-stage cases. Additionally, the consensus recommendations emphasize the necessity of addressing psychosocial factors and long-term follow-up. Dr. Park shifted focus to CTCL in pregnant women, noting a rare occurrence of malignancy during pregnancy and the challenges posed in treatment due to limited data. Clinical considerations in pregnant patients include consultation on fertility preservation and adjustments to imaging techniques to reduce radiation exposure. Lastly, she addressed racial disparities in CTCL incidence, highlighting that Black patients, particularly young females, show a higher incidence and often present at advanced stages, resulting in poorer outcomes, but they also demonstrate responsiveness to specific treatments, such as total skin electron beam radiation.
View moreConclusions
- Pediatric cutaneous lymphoma is rare, with an incidence of 0.1-0.3 cases per million in children from ages 0 to 19.
- Mycosis fungoides is the most common type of cutaneous lymphoma found in pediatric patients, followed by lymphomatoid papulosis and primary cutaneous B-cell lymphoma.
- Pediatric patients diagnosed with mycosis fungoides typically present at early stages, with up to 97% being early stage at diagnosis.
- Hypopigmented mycosis fungoides is prevalent in pediatric patients, particularly among those with skin of color.
- There is a noted male predominance in pediatric cutaneous lymphoma cases, though the studies also report an increasing incidence in young black females with worse outcomes and higher stage at diagnosis.
- Delays in diagnosis are common and can range from one to five years, sometimes reported as long as 14-24 years, often due to misleading benign dermatosis appearances.
- Most pediatric cutaneous lymphomas have an excellent prognosis, with disease-specific survival rates around 95% over ten years, though monitoring for progression is essential due to the potential for recurrent episodes.
- Clinically, skin-directed treatments such as phototherapy and topical steroids are effective and safe for treating pediatric cutaneous lymphomas.
- Future management guidelines should include regular follow-ups and consider the unique presentations and treatment responses among different racial and ethnic groups.
- International Journal of Hematology (2018) 108:203-207
- JAMA DERMATOLOGY. 2013;149:1295-1299
- Clinical and Experimental Dermatology, Volume 50, Issue 2, February 2025, Pages 279-286
- CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA, VOL. 24, NO. 4, E174-E180
- J Am Acad Dermatol. 2009 Feb;60(2):231-5
- Am J Clin Oncol 2013;36:481-485
- Chen, et al.